ICM
GDRX icon

Invenomic Capital Management’s GoodRx Holdings GDRX Stock Holding History

Invenomic Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-494,207
Closed -$3.31M – 160
2023
Q4 		$3.31M Sell
494,207
-811,989
-62% -$4.57M 0.15% 125
2023
Q3 		$7.35M Buy
+1,306,196
New +$8.71M 0.31% 80

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Invenomic Capital Management's GDRX Position: Q1 2024 in Review

Invenomic Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 494,207 shares — an estimated $3.31M sold.

Invenomic Capital Management first reported a position in GDRX in Q3 2023 and held it in 2 quarters. The position peaked at $7.35M in Q3 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • Invenomic Capital Management reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 494,207 GoodRx Holdings shares in Q1 2024, an estimated $3.31M.
  • Invenomic Capital Management first reported a position in GoodRx Holdings in Q3 2023 and held it in 2 quarters.
  • Invenomic Capital Management's GoodRx Holdings position peaked at $7.35M in Q3 2023.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.